290. Chronic nonspecific multiple ulcers of the small intestine Clinical trials / Disease details
Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathway : 1
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000030327 | 2017/12/25 | 22/12/2017 | Proof-of-concept clinical trial of lubiprostone's effect on chronic enteropathy associated with SLCO2A1 | Proof-of-concept clinical trial of lubiprostone's effect on chronic enteropathy associated with SLCO2A1 - LEAC study | Nonspecific multiple ulcers in the small intestine unrelated to NSAID (Chronic enteropathy associated with SLCO2A1: CEAS) | lubiprostone(12 micrograms) for 8 weeks | Fujita Health University, Department of Gastroenterology | NULL | Complete: follow-up complete | 20years-old | 80years-old | Male and Female | 8 | Phase 1,2 | Japan |